Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation.

Stephanie M YoonRobert SuhFereidoun AbtinDrew MoghanakiScott GenshaftMitchell KamravaAlexandra DrakakiSandy LiuPuja VenkatAlan LeeAlbert J Chang

Published in: Radiation oncology (London, England) (2021)

Percutaneous HDR brachyablation is a safe and promising treatment option for centrally located primary and metastatic lung tumors. Future comparisons with stereotactic body radiotherapy and other ablative techniques are warranted to expand multi-disciplinary management options.

Keyphrases

high dose
minimally invasive
squamous cell carcinoma
ultrasound guided
early stage
small cell lung cancer
radiofrequency ablation
low dose
radiation therapy
magnetic resonance imaging
current status
radiation induced
contrast enhanced
image quality
metabolic syndrome
dual energy
magnetic resonance
skeletal muscle